Se espera que el mercado mundial de monitoreo fetal crezca a una tasa compuesta anual del 4,51 % entre 2020 y 2029. Se espera que alcance más de USD 5800 millones para 2029 desde USD 3900 millones en 2020.
El aumento de la prevalencia de complicaciones relacionadas con el embarazo, como la diabetes gestacional , la hipertensión y el parto prematuro, ha puesto de relieve la importancia de la monitorización fetal para evaluar atentamente el bienestar fetal e identificar rápidamente las posibles complicaciones. La monitorización fetal facilita las intervenciones oportunas y el manejo juicioso de los embarazos complicados. Las soluciones emergentes de monitorización fetal, como los sistemas basados en software y telemetría , han obtenido una adopción generalizada, en particular en los países en desarrollo y subdesarrollados. Las previsiones sugieren un aumento proporcional del gasto sanitario en países como India y China, en consonancia con su expansión económica, lo que fomenta el crecimiento del mercado de la monitorización fetal.
Los avances tecnológicos en los aparatos de monitoreo fetal, como los sistemas de ultrasonidos y los dispositivos fetales portátiles, han mejorado notablemente la precisión y la eficacia del monitoreo, impulsando así la expansión del mercado. Las funcionalidades mejoradas que abarcan el análisis de datos en tiempo real, la conectividad inalámbrica y la portabilidad han aumentado la comodidad del monitoreo tanto para los profesionales de la salud como para las futuras madres. En consecuencia, la convergencia de innovaciones tecnológicas con soluciones rentables en estas regiones presenta oportunidades atractivas dentro del mercado de monitoreo fetal.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Millones de USD |
| Segmentación | Por tipo, portabilidad y método |
| Por tipo |
|
| Por portabilidad |
|
| Por método |
|
| Por región |
|
Además, las iniciativas gubernamentales y los marcos de políticas destinados a mejorar la salud materna e infantil han impulsado la adopción de la monitorización fetal en la atención prenatal. Cabe destacar que iniciativas como el Grupo de Trabajo de Salud Materna, Infantil y del Niño, un componente de Healthy People 2030 del Departamento de Salud y Servicios Humanos de los Estados Unidos, están orientadas a reducir las tasas de enfermedades y mortalidad entre mujeres, bebés y niños. Estas iniciativas priorizan la reducción de las complicaciones relacionadas con el embarazo, la ampliación del acceso a una atención sanitaria de alta calidad, el fomento de conductas conscientes de la salud y la resolución de las disparidades en la atención sanitaria. Estos esfuerzos concertados de entidades gubernamentales y no gubernamentales sirven como catalizadores para impulsar el crecimiento dentro de la industria de la monitorización fetal.
The fetal monitoring market size had crossed USD 3.9 Billion in 2020 and will observe a CAGR of more than 4.51% up to 2027.
Product launches and approvals, agreements and partnerships, expansions, and acquisitions are among the primary growth tactics employed by the market's leading companies.
The high cost of fetal monitoring monitors is projected to be the key factor limiting the growth of the fetal monitoring industry.
The global fetal monitoring market registered a CAGR of 4.51% from 2022 to 2029.
Key players profiled in the report include Cardinal Health Inc., Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, FUJIFILM SonoSite Inc., Nat Medical Incorporated, Huntleigh Healthcare Limited, The Cooper Companies Inc. , CONTEC Medical Systems Co.Ltd. , EDAN Diagnostics Inc. , Neoventa Medical AB,Bionet Co.Ltd. , Progetti Srl ,TRIMMED Co.Ltd. , ShenZhen Luckcome Technology Inc.,MedGyn Products Inc , Dixion,Promed Group Co.Ltd. , Advanced Instrumentations , BRAEL-Medical Equipment, GPC Medical,BISTOS ,Mediana,Life Pl ,ChoiceMMed,Trivitron Healthcare, Dott Medical Co. Ltd., Monarch Meditech, Shenzhen Comen Medical Instruments Co.Ltd
The ultrasound segment is projected to be the fastest-growing segment in the fetal monitoring market.
North America is the largest regional market for the fetal monitoring market.
On the basis of Type, the fetal monitoring market is divided into ultrasound devices, electronic maternal/fetal monitors, uterine contraction monitors, fetal electrodes, fetal doppler devices, telemetry devices, accessories, and consumables. The ultrasound segment dominated the worldwide market, and this trend is expected to continue during the projected period. The primary reasons driving the growth of the fetal monitoring market include an increase in the number of post-term pregnancies, multiple pregnancies, and preterm birth cases, as well as a surge in demand for the fetal monitoring market.
Based on Portability, the fetal monitoring market is divided into portable systems and non-portable systems. The non-portable category dominated the worldwide market, and this trend is expected to continue throughout the projected period. These non-portable fetal monitoring devices deliver precise diagnostic and performance outcomes.
Based on Method, the fetal monitoring market is segmented into invasive, and noninvasive. The non-invasive category dominated the worldwide market, and this trend is expected to continue during the projected period. Furthermore, the advancement of wireless, portable, and small non-invasive fetal monitoring devices, which are safe and simple to use, also fuels market expansion.
[caption id="attachment_9461" align="alignleft" width="680"]
From large companies to small ones, many companies are actively working in the fetal monitoring market. These key players include Cardinal Health Inc., Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, FUJIFILM SonoSite Inc., Nat Medical Incorporated, Huntleigh Healthcare Limited, The Cooper Companies Inc. ,CONTEC Medical Systems Co.Ltd. , EDAN Diagnostics Inc. ,Neoventa Medical AB ,Bionet Co.Ltd. ,Progetti Srl ,TRISMED Co.Ltd. ,ShenZhen Luckcome Technology Inc. ,MedGyn Products Inc ,Dixion ,Promed Group Co.Ltd. ,Advanced Instrumentations ,BRAEL-Medical Equipment ,GPC Medical ,BISTOS ,Mediana ,Life Pl ,ChoiceMMed ,Trivitron Healthcare ,Dott Medical Co. Ltd. ,Monarch Meditech, Shenzhen Comen Medical Instruments Co.Ltd. and others.
Companies are mainly in fetal monitoring they are competing closely with each other. Innovation is one of the most important key strategies as it has to be for any market. However, companies in the market have also opted for and successfully driven inorganic growth strategies like mergers & acquisitions, and so on.
The fetal monitoring market by region includes North America, Middle East & Africa (MEA), Europe, South America, and Asia-Pacific (APAC).
Its major share is occupied by North America, Asia Pacific, Middle East & Africa (MEA), and Europe region. The North America shares 36% of the total market.
[caption id="attachment_9462" align="alignleft" width="680"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.